Insulin Complications Flashcards
Signs and symptoms of hypoglycemia
Tremors, diaphoresis, anxiety, dizziness, hunger, tachycardia, blurred vision, weakness/drowsiness, headache l, irritability, confusion, slurred speech
Why can’t we take beta blockers for hypoglycemia
It decreases the responsiveness to hypoglycemia because it blocks the sympathetic warning symptoms
Treatment of hypoglycemia
Start with 15 grams of fast acting carbon hydrate. Wait for 15 minutes then check blood sugar. If it is less than 70 then repeat with another round of 15 grams of fast acting carbohydrate. Follow this with a complex carbon hydrate or with a meal. Take 30 grams of complex carb if meal is more than an hour away
Examples of 15 g of fast acting carb
4 ounces of orange juice, 5-6 lifesavers, 2 tsp of sugar(white or brown only), 6 ounces of cola, and 3 or 4 glucose tablets/gels
Examples of complex carbohydrates
Granola bars, peanut butter sandwich, crackers with peanut butter or cheese
Drugs to give level 2 or 3 hypoglycemic patients
3 mg of Baqsimi intranasal. 0.6 mg SQ dasiglucagon(zegalogue). 1mg SQ, IM, or IV gvoke hypopen or Glucapen
List complications of insulin
Hypoglycemia, weight gain, lipohypertrophy, Lipoatrophy
Advantages of short acting insulins
Decreases post prandial hyperglycemia. Has superior post prandial ability of reducing blood sugars. Has lesser nocturnal hypoglycemia. Fewer occurrence of hypoglycemia. Greater flexibility
Disadvantages of short acting insulins
Risk of hypoglycemia if you don’t eat a meal within 15 minutes of dose. Need to combine with a longer acting insulin for optimal control of blood sugar . More expensive compared to regular insulins Hyperglycemia/ ketosis May occur rapidly if insulin delivery is interrupted. If you mix with another insulin you will need to give immediately
Advantages of long acting insulins
Beneficial for patients who may be experiencing nocturnal hypoglycemia. Provides 24 hours coverage with no pronounced peak
Disadvantages of long acting insulins
Increased breast, colon and pancreatic cancer in patients with glargine compared to the other types of insulins. Cannot be mixed with other insulins. More expensive compared to NPH
What did the devote trial show
Glargine had a higher risk of non fatal MI and strokes compared to Degludec. Glargine had a higher risk of hypoglycemia compared to Degludec l
Dosing principle of changing U-100 NPH to a long acting insulin U-100
The dose stays the same
Dosing principle of changing U-100 BID NPH to U-100 long acting insulins
Decrease long acting insulin dose by 20%
Dosing principles for U-100 to a more concentrated therapy for BID NPH to U-300 glargine
Reduce dose by 20 percent